PHOENIX, AZ (August 27, 2025) – The Arizona Commerce Authority (ACA) today announced 10 awardees have been selected for the Fall 2025 Arizona Innovation Challenge (AIC). The Fall 2025 cohort includes some of the state’s most promising Software as a Service (SaaS)/AI startups.
Category Archives: AZBio News
Discovery could lead to new treatments for life-threatening allergic reactions
ASU researchers probe how the gut responds to severe food allergiesContinue reading
Edson seed grants awarded to explore clues behind neurodegenerative diseases
5 ASU researchers will use the awards as opportunities for high-impact studiesContinue reading
GT Medical Technologies Reaches Clinical Milestone of 2,000th Patients Treated with GammaTile®
Highlighting growing adoption of innovative brain tumor treatment across the United States
Virginia G. Piper Charitable Trust Awards $6 Million in Grants to Advance Higher Education in Maricopa County
Individual grants of $1 million were awarded to Arizona State University, Creighton University, Grand Canyon University, Maricopa Community Colleges, Northern Arizona University, and University of Arizona.
Jocasta Neuroscience Lands $35 Million Series A to Advance Longevity Protein Program for Managing Cognitive Impairment
Funding to support development of proprietary * a -Klotho *protein therapeutic targeting cognitive decline in neurodegenerative diseasesContinue reading
AdvaMed, Patient Groups, State Medtech Associations Urge Medicare Coverage of Breakthrough Medtech
In a letter to CMS Administrator Dr. Mehmet Oz, the 67 organizations noted medtech enables remarkable patient outcomes, yet FDA-designated, authorized breakthrough medtech faces years of delays in Medicare coverage. Continue reading
Clinical and medical-education pioneer to forge links throughout HonorHealth Research Institute, emphasizing disease prevention
Dr. Goetz helps lead unprecedented effort to advance new laboratory discoveries, quickly benefiting patients throughout HonorHealth’s research networkContinue reading
AZBioPEERS Tales from the Road with Kiran Avancha
In this enlightening conversation with Kiran Avancha, co-founder of priZm Therapeutics, a late-stage clinical biotech company based in Chandler, Arizona shares his journey building a company focused on developing breakthrough therapies for ultra-rare pediatric diseases—including their lead program, SRW101, a novel synthetic T3 molecule for treating AHDS (Allan-Herndon-Dudley Syndrome).Continue reading